Technology
Health
Biotechnology

Trevena

$1.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (3.42%) Today
+$0.01 (0.83%) After Hours

Why Robinhood?

You can buy or sell Trevena and other stocks, options, ETFs, and crypto commission-free!

About

Trevena, Inc. Common Stock, also called Trevena, is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. Read More The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

Employees
29
Headquarters
Chesterbrook, Pennsylvania
Founded
2007
Market Cap
108.05M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.65M
High Today
$1.23
Low Today
$1.15
Open Price
$1.15
Volume
406.19K
52 Week High
$3.58
52 Week Low
$0.3823

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2014 IPO
US
North America

News

Yahoo FinanceMay 10

Trevena: 1Q Earnings Snapshot

CHESTERBROOK, Pa. (AP) _ Trevena Inc. (TRVN) on Friday reported a loss of $5.2 million in its first quarter. On a per-share basis, the Chesterbrook, Pennsylvania-based company said it had a loss of 6 cents. The company's shares closed at $1.55. A year ago, they were trading at $1.98. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRVN at https://www.zacks.com/ap/TRVN...

1,063
Simply Wall StApr 26

Trevena, Inc. (NASDAQ:TRVN): Will The Growth Last?

The latest earnings announcement Trevena, Inc. (NASDAQ:TRVN) released in December 2018 showed company earnings became less negative compared to the previous year’s level as a result of recent tailwinds Investors may find it useful to understand how market analysts perceive Trevena’s earnings growth trajectory over the next couple of years and whether the future looks brighter. I will be looking at earnings excluding extraordinary items to exclude one-off activities to get a better understanding of the under...

1,530

Earnings

-$0.33
-$0.24
-$0.15
-$0.06
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.08 per share
Actual
-$0.06 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.